To further shed light on the crucial role of LKB1/AMPK signaling in anti-metastatic effect of oridonin on laryngeal carcinoma, compound C (ComC, AMPK inhibitor) and AICAR (AMPK activator) were used to collaborate with oridonin for the subsequent experiments. The gene discussed is STK11; the disease is laryngeal carcinoma.